NCT00583999

The Role of Leptin Receptors in NASH

Leptin, Soluble Leptin Receptor and Adiponectin in Non Alcoholic Steatohepatitis

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 104 (actual)
• Sponsor: University of California, Davis · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

NAFLD is a spectrum of liver diseases associated with varying degrees of hepatic steatosis, inflammation, and in some cases, fibrosis. NAFLD is a common observation in all demographics, but the prevalence of NAFLD and nonalcoholic steatohepatitis (NASH) is especially high in the morbidly obese population. Leptin is a cytokine that is encoded by the ob gene and primarily secreted by adipose tissue. The production of serum leptin increases with progressive obesity. Because of this observation, there has been significant interest in potential role of leptin in NAFLD. Our hypothesis is that we will find increased hepatic leptin and leptin receptor expression as the degree of hepatic injury worsens in NAFLD.

Conditions

• Nonalcoholic Steatohepatitis
• Metabolic Syndrome

Interventions

Type	Name	Description
OTHER	no interventions, only regular blood-draw	No interventions, only regular blood-draw (liver biopsy obtained per routine during the surgery)

Timeline

• Start date: 2006-01-01
• Primary completion: 2009-06-01
• Completion: 2009-06-01
• First posted: 2008-01-02
• Last updated: 2017-05-30

Locations

1 site across 1 country: United States